Recruiting PHASE2 INTERVENTIONAL 2-arm NCT06925295

Using Xe MRI to Guide Radiation Therapy for Lung Cancer ((XeRTLC))

Image-Based Functionally Adapted Radiation Therapy for Lung Cancer

Sponsor: Sean Fain

Interventions Blood Biomarkers Medical Research Council Dyspnea score Pulmonary Function Testing Quality of Life Questionnaire St. George's Respiratory Questionnaire Xenon MRI

Updated 3 times since 2025 Last updated: Dec 30, 2025 Started: Aug 30, 2025 Primary completion: Jan 31, 2027 Completion: Jan 31, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06925295, this PHASE2 trial focuses on Imaging Techniques and remains actively recruiting participants. Sponsored by Sean Fain, it has been updated 3 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Feb 2026 — Present [monthly]

Recruiting PHASE2
Aug 2025 — Feb 2026 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
May 2025 — Aug 2025 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sean Fain

Data source: University of Iowa

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Iowa City, United States